Patent · US Active

Organic compounds

US7989441B2 · kind B2 · utility

2Cited by

1References

8Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Zhuoliang Chen · Cambridge, US
Mark G. Palermo · Rindge, US
Sushil Sharma · East Hanover, US
Troy Douglas Smith · Nashua, US
Christopher Sean Straub · Cambridge, US
Run-Ming David Wang · Cambridge, US
Yaping Wang · Cambridge, US
Leigh Zawel · Bowie, US

Key dates

Filing date	Jun 6, 2006
Grant date	Aug 2, 2011
Priority date	—
Expiry date	Jan 6, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/1008
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present disclosure relates to XIAP inhibitor compounds of the formula I.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.